Pathology and pathogenesis of Chagas heart disease

KM Bonney, DJ Luthringer, SA Kim… - Annual Review of …, 2019 - annualreviews.org
Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately
one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T …

Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment

EA Bocchi, RB Bestetti, MI Scanavacca… - Journal of the American …, 2017 - jacc.org
Trypanosoma cruzi (T. cruzi) infection is endemic in Latin America and is becoming a
worldwide health burden. It may lead to heterogeneous phenotypes. Early diagnosis of T …

Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America

J Alonso-Padilla, N Cortés-Serra… - Expert review of anti …, 2019 - Taylor & Francis
Introduction: Chagas disease, caused by infection with the parasite Trypanosoma cruzi,
represents a huge public health problem in the Americas, where millions of people are …

[HTML][HTML] Diagnosis and clinical management of Chagas disease: An increasing challenge in non-endemic areas

C Suárez, D Nolder, A García-Mingo… - Research and reports …, 2022 - ncbi.nlm.nih.gov
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in
Central, South America, Mexico and the South of the United States. It is an important cause …

Treatment of Chagas disease in the United States

S Meymandi, S Hernandez, S Park… - … treatment options in …, 2018 - Springer
Abstract Purpose of Review Chagas disease (CD) is endemic to much of Latin America, but
also present in the United States (US). Following a lengthy asymptomatic period, CD …

[HTML][HTML] Immunity and vaccine development efforts against Trypanosoma cruzi

LE Rios, JC Vázquez-Chagoyán, AO Pacheco… - Acta tropica, 2019 - Elsevier
Trypanosoma cruzi (T. cruzi) is the causative agent for Chagas disease (CD). There is a
critical lack of methods for prevention of infection or treatment of acute infection and chronic …

Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study

AM Hasslocher-Moreno, RM Saraiva… - …, 2021 - thelancet.com
Background Chagas disease (CD) remains an important endemic disease in Latin America.
However, CD became globalized in recent decades. The majority of the chronically infected …

Infectious diseases causing autonomic dysfunction

FJ Carod-Artal - Clinical Autonomic Research, 2018 - Springer
Objectives To review infectious diseases that may cause autonomic dysfunction. Methods
Review of published papers indexed in medline/embase. Results Autonomic dysfunction …

SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of chagas disease–2023

JA Marin-Neto, A Rassi Jr, GMM Oliveira… - Arquivos Brasileiros …, 2023 - SciELO Brasil
SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

Review of pharmacological options for the treatment of Chagas disease

F Lascano, F García Bournissen… - British journal of clinical …, 2022 - Wiley Online Library
Chagas disease (CD) is a worldwide problem, with over 8 million people infected in both
rural and urban areas. CD was first described over a century ago, but only two drugs are …